Filing metadata

Accession number
0001127602-21-013551
Form type
Form 3
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Apr 09, 2021
Reporting period
Mar 30, 2021
Description
Initial ownership

Explore SEC Filings Hub